|
Market Closed -
NYSE
16:00:02 2026-08-18 EDT
|
5-day change | 1st Jan Change | ||
| 1.030 USD | -6.36% |
|
-12.71% | -70.82% |
| 08-14 | ADC Therapeutics Balances LOTIS-5 Regulatory Risk With LOTIS-7 Opportunity, RBC Says | MT |
| 08-13 | ADC Therapeutics SA, Q2 2026 Earnings Call, Aug 13, 2026 |
Chart: Technical Analysis
Stock exchange
NYSE
ADCT 1.030 $
-6.36%
3.55M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
NYSE
| ADCT | 1.030USD | -6.36% | 3.55M $ | |
CBOE
| ADCT | 1.035USD | -5.05% | 38.85K $ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 1.15 | 2.12 | 2.03 |
| Spread/Res. | -10.43% | -51.42% | -49.26% |
| Spread/Supp. | +1.98% | +5.35% | +1.98% |
| Support | 1.01 | 0.9777 | 1.01 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ADCT Stock
- Charts ADC Therapeutics SA
Select your edition
All financial news and data tailored to specific country editions
